276 related articles for article (PubMed ID: 16691038)
21. Application of SNaPshot for analysis of thiopurine methyltransferase gene polymorphism.
Kapoor G; Maitra A; ; Brahmachari V
Indian J Med Res; 2009 May; 129(5):500-5. PubMed ID: 19675376
[TBL] [Abstract][Full Text] [Related]
22. Genetic polymorphism of thiopurine S-methyltransferase in Argentina.
Laróvere LE; de Kremer RD; Lambooy LH; De Abreu RA
Ann Clin Biochem; 2003 Jul; 40(Pt 4):388-93. PubMed ID: 12880540
[TBL] [Abstract][Full Text] [Related]
23. Duplex pyrosequencing of the TPMT*3C and TPMT*6 alleles in Korean and Vietnamese populations.
Lee SS; Kim WY; Jang YJ; Shin JG
Clin Chim Acta; 2008 Dec; 398(1-2):82-5. PubMed ID: 18775689
[TBL] [Abstract][Full Text] [Related]
24. Thiopurine S-methyltransferase genetic polymorphism in the Thai population.
Srimartpirom S; Tassaneeyakul W; Kukongviriyapan V; Tassaneeyakul W
Br J Clin Pharmacol; 2004 Jul; 58(1):66-70. PubMed ID: 15206995
[TBL] [Abstract][Full Text] [Related]
25. High prevalence of polymorphism and low activity of thiopurine methyltransferase in patients with inflammatory bowel disease.
Larussa T; Suraci E; Lentini M; Nazionale I; Gallo L; Abenavoli L; Imeneo M; Costanzo FS; Cuda G; Luzza F
Eur J Intern Med; 2012 Apr; 23(3):273-7. PubMed ID: 22385887
[TBL] [Abstract][Full Text] [Related]
26. Screening of thiopurine S-methyltransferase mutations by horizontal conformation-sensitive gel electrophoresis.
Alves S; Prata MJ; Ferreira F; Amorim A
Hum Mutat; 2000; 15(3):246-53. PubMed ID: 10679940
[TBL] [Abstract][Full Text] [Related]
27. Pharmacogenetics of human erythrocyte thiopurine methyltransferase activity in a French population.
Tinel M; Berson A; Pessayre D; Letteron P; Cattoni MP; Horsmans Y; Larrey D
Br J Clin Pharmacol; 1991 Dec; 32(6):729-34. PubMed ID: 1768566
[TBL] [Abstract][Full Text] [Related]
28. Thiopurine S-methyltransferase (TPMT) assessment prior to starting thiopurine drug treatment; a pharmacogenomic test whose time has come.
Ford LT; Berg JD
J Clin Pathol; 2010 Apr; 63(4):288-95. PubMed ID: 20354201
[TBL] [Abstract][Full Text] [Related]
29. Thiopurine S-methyltransferase (TPMT) pharmacogenetics: three new mutations and haplotype analysis in the Estonian population.
Tamm R; Oselin K; Kallassalu K; Magi R; Anier K; Remm M; Metspalu A
Clin Chem Lab Med; 2008; 46(7):974-9. PubMed ID: 18605963
[TBL] [Abstract][Full Text] [Related]
30. Analysis of thiopurine S-methyltransferase phenotype-genotype in a Tunisian population with Crohn's disease.
Ben Salah L; Belkhiria el Haj Amor M; Chbili C; Khlifi S; Fathallah N; Bougmiza I; Ben Jazia E; Houdret N; Ben Salem C; Saguem S
Eur J Drug Metab Pharmacokinet; 2013 Dec; 38(4):241-4. PubMed ID: 23553048
[TBL] [Abstract][Full Text] [Related]
31. Clinical pharmacogenomics of thiopurine S-methyltransferase.
Zhou S
Curr Clin Pharmacol; 2006 Jan; 1(1):119-28. PubMed ID: 18666383
[TBL] [Abstract][Full Text] [Related]
32. [New techniques for optimization of thiopurine therapy in leukemia and transplantation].
Loennechen T; Lysaa RA; Giverhaug T; Sylte I; Mathiesen LE; Aarbakke J
Tidsskr Nor Laegeforen; 2002 Apr; 122(11):1107-10. PubMed ID: 12043054
[TBL] [Abstract][Full Text] [Related]
33. The low frequency of defective TPMT alleles in Turkish population: a study on pediatric patients with acute lymphoblastic leukemia.
Tumer TB; Ulusoy G; Adali O; Sahin G; Gozdasoglu S; Arinç E
Am J Hematol; 2007 Oct; 82(10):906-10. PubMed ID: 17617792
[TBL] [Abstract][Full Text] [Related]
34. Explaining TPMT genotype/phenotype discrepancy by haplotyping of TPMT*3A and identification of a novel sequence variant, TPMT*23.
Lindqvist M; Skoglund K; Karlgren A; Söderkvist P; Peterson C; Kidhall I; Almer S
Pharmacogenet Genomics; 2007 Oct; 17(10):891-5. PubMed ID: 17885628
[TBL] [Abstract][Full Text] [Related]
35. Frequencies of thiopurine S-methyltransferase mutant alleles (TPMT*2, *3A, *3B and *3C) in 151 healthy Japanese subjects and the inheritance of TPMT*3C in the family of a propositus.
Kubota T; Chiba K
Br J Clin Pharmacol; 2001 May; 51(5):475-7. PubMed ID: 11422006
[TBL] [Abstract][Full Text] [Related]
36. Segregation analysis of human red blood cell thiopurine methyltransferase activity.
Vuchetich JP; Weinshilboum RM; Price RA
Genet Epidemiol; 1995; 12(1):1-11. PubMed ID: 7713396
[TBL] [Abstract][Full Text] [Related]
37. Individualization of thiopurine therapy: thiopurine S-methyltransferase and beyond.
Karas-Kuzelicki N; Mlinaric-Rascan I
Pharmacogenomics; 2009 Aug; 10(8):1309-22. PubMed ID: 19663675
[TBL] [Abstract][Full Text] [Related]
38. Pharmacogenetic studies of thiopurine methyltransferase genotype-phenotype concordance and effect of methotrexate on thiopurine metabolism.
Zimdahl Kahlin A; Helander S; Wennerstrand P; Vikingsson S; Mårtensson LG; Appell ML
Basic Clin Pharmacol Toxicol; 2021 Jan; 128(1):52-65. PubMed ID: 32865889
[TBL] [Abstract][Full Text] [Related]
39. Thiopurine methyltransferase activity in a Korean population sample of children.
Park-Hah JO; Klemetsdal B; Lysaa R; Choi KH; Aarbakke J
Clin Pharmacol Ther; 1996 Jul; 60(1):68-74. PubMed ID: 8689814
[TBL] [Abstract][Full Text] [Related]
40. Genetic determinants of the pre- and post-azathioprine therapy thiopurine methyltransferase activity phenotype.
Arenas M; Duley JA; Ansari A; Shobowale-Bakre EA; Fairbanks L; Soon SY; Sanderson J; Marinaki AM
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1403-5. PubMed ID: 15571267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
